Lv1
28 积分 2025-05-06 加入
Targeting KRAS in cancer
1天前
待确认
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
1个月前
已完结
8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models
1个月前
已完结
Cancer vaccines: Discovery, development, and challenges for clinical translation
1个月前
已完结
Application prospects of tumor vaccines for pancreatic cancer: From TAAs to TSAs and combination strategies
1个月前
已关闭
Pancreatic cancer in the era of precision medicine: challenges, advances, and the future of therapeutic strategies
1个月前
已完结
The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges
2个月前
已完结
Advances in biomarkers of resistance to KRAS mutation-targeted inhibitors
2个月前
已完结
Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
2个月前
已完结
An overview of PROTACs targeting KRAS and SOS1 as antitumor agents
2个月前
已完结
皖公网安备34019202002308
